The first platform built entirely around multi-RNA combination medicines.
Silencing what's broken. Activating what heals.
Beyond single targets
The SymphoRNA advantage
The biggest unmet needs in medicine aren’t caused by a single faulty gene. They're driven by complex biological networks.
Conditions like fibrosis, heart failure, and neurodegeneration are driven by multiple biological pathways going wrong at once, simultaneously and synergistically.
RNA is the only modality built to solve multi-target problems with precision and tissue breadth
A multi-RNA combination engine
A systematic process for identifying and combining mRNA + siRNA targets that work synergistically, turning multiple disease pathways up or down in concert.
Novel polysaccharide delivery system
Is safe for repeated, chronic dosing
Is biodegradable and enables slow release
Has strong tropism to target tissues
Delivers multiple RNA types simultaneously
Easily tunable with a broad IP white space